Catheter ablation of premature ventricular complexes with low intraprocedural burden guided exclusively by pace‐mapping. (29th August 2019)

• Record Type: Journal Article
• Authors: Shirai, Yasuhiro; Liang, Jackson J.; Santangeli, Pasquale; Supple, Gregory E.; Riley, Michael P.; Garcia, Fermin C.; Lin, David; Dixit, Sanjay; Callans, David J.; Marchlinski, Francis E.; Frankel, David S.; Schaller, Robert D.
• Is Part Of: Journal of cardiovascular electrophysiology. Volume 30:Number 11(2019)
• Page Start: 2326
• Page End: 2333
• Publication Date: 2019-08-29
• Subjects: activation mapping -- catheter ablation -- pace‐mapping -- premature ventricular complex; Blood vessels -- Physiology -- Periodicals; Electrophysiology -- Periodicals; Heart -- Physiology -- Periodicals; 612.1
• DOI: 10.1111/jce.14127
• Languages: English
• ISSNs: 1045-3873

Abstract

Abstract: Background: Catheter ablation (CA) of idiopathic premature ventricular complexes (PVCs) is typically guided by both activation and pace‐mapping, with ablation ideally delivered at the site of the earliest local activation. However, activation mapping requires sufficient intraprocedural quantity of PVCs. This study aimed to investigate the outcome of CA of infrequent PVCs guided exclusively by pace‐mapping. Methods: We retrospectively analyzed all patients undergoing CA of idiopathic PVCs between 2014 and 2017. Results: Among 327 patients, 24 (7.3%) had low intraprocedural PVC burden despite isoproterenol, including two patients with zero PVCs, rendering activation mapping impractical/impossible. All 24 had a history of symptomatic PVCs. During ablation, a median of 27 (17‐55) pace‐maps were performed, with best median PASO score of 97 (96‐98)%. A median of 12 (8.75‐18.75) radiofrequency (RF) lesions were delivered with 11.4 (8.5‐17.6) minutes of total RF time. Clinical success, defined as more than 80% reduction in the burden of previously frequent PVCs and/or absence of symptoms as well as any documented clinical PVCs among those with infrequent or exercise‐induced PVCs, was achieved in 19 (79%) patients over 9.2 (2.0‐15.0) months of follow‐up. Conclusions: When activation mapping cannot be performed due to inadequate intraprocedural PVC burden, detailed pace‐mapping can frequently identify the precise arrhythmia site of origin, thereby guiding successful CA.